{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:50:28Z","timestamp":1792266628720,"version":"4.4.0"},"reference-count":194,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in December 2019 with staggering economic fallout and human suffering. The unique structure of SARS-CoV-2 and its underlying pathogenic mechanism were responsible for the global pandemic. In addition to the direct damage caused by the virus, SARS-CoV-2 triggers an abnormal immune response leading to a cytokine storm, culminating in acute respiratory distress syndrome and other fatal diseases that pose a significant challenge to clinicians. Therefore, potential treatments should focus not only on eliminating the virus but also on alleviating or controlling acute immune\/inflammatory responses. Current management strategies for COVID-19 include preventative measures and supportive care, while the role of the host immune\/inflammatory response in disease progression has largely been overlooked. Understanding the interaction between SARS-CoV-2 and its receptors, as well as the underlying pathogenesis, has proven to be helpful for disease prevention, early recognition of disease progression, vaccine development, and interventions aimed at reducing immunopathology have been shown to reduce adverse clinical outcomes and improve prognosis. Moreover, several key mutations in the SARS-CoV-2 genome sequence result in an enhanced binding affinity to the host cell receptor, or produce immune escape, leading to either increased virus transmissibility or virulence of variants that carry these mutations. This review characterizes the structural features of SARS-CoV-2, its variants, and their interaction with the immune system, emphasizing the role of dysfunctional immune responses and cytokine storm in disease progression. Additionally, potential therapeutic options are reviewed, providing critical insights into disease management, exploring effective approaches to deal with the public health crises caused by SARS-CoV-2.<\/jats:p>","DOI":"10.3389\/fmicb.2024.1334152","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T04:57:15Z","timestamp":1718254635000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines"],"prefix":"10.3389","volume":"15","author":[{"given":"Xi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ijid.2021.12.357","article-title":"Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, South Africa","volume":"116","author":"Abdullah","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1056\/NEJMc2104974","article-title":"Effectiveness of the BNT162b2 Covid-19 vaccine against the B.1.1.7 and B.1.351 variants","volume":"385","author":"Abu-Raddad","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular Endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.cell.2022.02.005","article-title":"Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2","volume":"185","author":"Afkhami","year":"2022","journal-title":"Cell"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1136\/jnnp-2022-330885","article-title":"Functional neurological disorders after COVID-19 and SARS-CoV-2 vaccines: a national multicentre observational study","volume":"94","author":"Alonso-Canovas","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"103841","DOI":"10.1016\/j.ebiom.2022.103841","article-title":"Intranasal COVID-19 vaccines: from bench to bed","volume":"76","author":"Alu","year":"2022","journal-title":"EBioMedicine"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"54118","DOI":"10.1073\/pnas.2103154118","article-title":"SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma","volume":"118","author":"Andreano","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41392-023-01724-w","article-title":"Strategies for the development and approval of COVID-19 vaccines and therapeutics in the post-pandemic period","volume":"8","author":"Ao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41586-020-2538-8","article-title":"A perspective on potential antibody-dependent enhancement of SARS-CoV-2","volume":"584","author":"Arvin","year":"2020","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1126\/science.abd0831","article-title":"Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies","volume":"369","author":"Baum","year":"2020","journal-title":"Science"},{"key":"ref11","first-page":"1247","article-title":"Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis","volume":"38","author":"Berardicurti","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.cmi.2021.05.022","article-title":"Novel SARS-CoV-2 variants: the pandemics within the pandemic","volume":"27","author":"Boehm","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/MCP.0000000000000761","article-title":"Pulmonary pathology of COVID-19: a review of autopsy studies","volume":"27","author":"Borczuk","year":"2021","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/path.5471","article-title":"Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)","volume":"251","author":"Bourgonje","year":"2020","journal-title":"J. Pathol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41577-020-00410-0","article-title":"The role of IgG fc receptors in antibody-dependent enhancement","volume":"20","author":"Bournazos","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref17","author":"Bricker","year":"2020"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1021\/acschemneuro.0c00596","article-title":"Chemosensory dysfunction in COVID-19: integration of genetic and epidemiological data points to D614G spike protein variant as a contributing factor","volume":"11","author":"Butowt","year":"2020","journal-title":"ACS Chem. Nerosci."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41586-021-04386-2","article-title":"Broadly neutralizing antibodies overcome SARS-CoV-2 omicron antigenic shift","volume":"602","author":"Cameroni","year":"2022","journal-title":"Nature"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.26633\/RPSP.2021.126","article-title":"SARS-CoV-2 variants in severely symptomatic and deceased persons who had been vaccinated against COVID-19 in S\u00e3o Paulo, Brazil","volume":"45","author":"Campos","year":"2021","journal-title":"Rev. Panam. Salud Publica"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1056\/NEJMoa2208822","article-title":"VV116 versus Nirmatrelvir-ritonavir for Oral treatment of Covid-19","volume":"388","author":"Cao","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3389\/fphar.2018.01157","article-title":"Anakinra therapy for non-cancer inflammatory diseases","volume":"9","author":"Cavalli","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1038\/s41591-021-01446-y","article-title":"mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar","volume":"27","author":"Chemaitelly","year":"2021","journal-title":"Nat. Med."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.scib.2022.05.018","article-title":"A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2","volume":"67","author":"Chen","year":"2022","journal-title":"Sci. Bull."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"106119","DOI":"10.1016\/j.ijsu.2021.106119","article-title":"Intranasal COVID-19 vaccines: is it a boon or bane?","volume":"94","author":"Choudhary","year":"2021","journal-title":"Int. J. Surg."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1093\/cid\/ciaa410","article-title":"Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19","volume":"71","author":"Chu","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e29209","DOI":"10.1002\/jmv.29209","article-title":"From viral democratic genomes to viral wild bunch of quasispecies","volume":"95","author":"Colson","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jinf.2021.12.018","article-title":"RNA viral loads of SARS-CoV-2 alpha and Delta variants in nasopharyngeal specimens at diagnosis stratified by age, clinical presentation and vaccination status","volume":"84","author":"Costa","year":"2022","journal-title":"J. Infect."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"E1417","DOI":"10.1073\/pnas.1108754108","article-title":"Fitness costs limit influenza a virus hemagglutinin glycosylation as an immune evasion strategy","volume":"108","author":"das","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1126\/science.abg3055","article-title":"Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England","volume":"372","author":"Davies","year":"2021","journal-title":"Science"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1172\/JCI36587","article-title":"Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response","volume":"119","author":"Dazert","year":"2009","journal-title":"J. Clin. Invest."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/2401081","article-title":"Angiotensin-(1-7) and Alamandine promote anti-inflammatory response in macrophages in vitro and in vivo","volume":"2019","author":"de Carvalho Santuchi","year":"2019","journal-title":"Mediators Inflamm."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"8396","DOI":"10.1126\/scitranslmed.abf8396","article-title":"COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters","volume":"13","author":"de Melo","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: recent insights into emerging coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.cell.2021.12.046","article-title":"SARS-CoV-2 omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses","volume":"185","author":"Dejnirattisai","year":"2022","journal-title":"Cell"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e2317851121","DOI":"10.1073\/pnas.2317851121","article-title":"Incipient functional SARS-CoV-2 diversification identified through neural network haplotype maps","volume":"121","author":"Delgado","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41586-022-04421-w","article-title":"The cGAS-STING pathway drives type I IFN immunopathology in COVID-19","volume":"603","author":"Domizio","year":"2022","journal-title":"Nature"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV--a target for vaccine and therapeutic development","volume":"7","author":"Du","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","article-title":"Neurological associations of COVID-19","volume":"19","author":"Ellul","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41392-022-00997-x","article-title":"SARS-CoV-2 omicron variant: recent progress and future perspectives","volume":"7","author":"Fan","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1126\/science.abh2644","article-title":"Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil","volume":"372","author":"Faria","year":"2021","journal-title":"Science"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1016\/j.cell.2022.06.008","article-title":"Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation","volume":"185","author":"Fern\u00e1ndez-Casta\u00f1eda","year":"2022","journal-title":"Cell"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.cmi.2021.10.005","article-title":"Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review","volume":"28","author":"Fiolet","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"E1619","DOI":"10.1503\/cmaj.211248","article-title":"Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada","volume":"193","author":"Fisman","year":"2021","journal-title":"J Assoc Med Can"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s11596-021-2395-1","article-title":"A comprehensive review of COVID-19 virology, vaccines, variants, and therapeutics","volume":"41","author":"Forchette","year":"2021","journal-title":"Curr Med Sci."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/all.14657","article-title":"Risk factors for severe and critically ill COVID-19 patients: a review","volume":"76","author":"Gao","year":"2021","journal-title":"Allergy"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.cell.2021.03.013","article-title":"Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity","volume":"184","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cell.2021.12.040","article-title":"Complement activation induces excessive T cell cytotoxicity in severe COVID-19","volume":"185","author":"Georg","year":"2022","journal-title":"Cell"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1126\/sciimmunol.abo2202","article-title":"Divergent SARS-CoV-2 omicron-reactive T and B cell responses in COVID-19 vaccine recipients","volume":"7","author":"GeurtsvanKessel","year":"2022","journal-title":"Sci Immunol."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.chom.2021.02.003","article-title":"Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies","volume":"29","author":"Greaney","year":"2021","journal-title":"Cell Host Microbe"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41593-024-01576-9","article-title":"Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment","volume":"27","author":"Greene","year":"2024","journal-title":"Nat. Neurosci."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41591-021-01676-0","article-title":"mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 omicron variant","volume":"28","author":"Gruell","year":"2022","journal-title":"Nat. Med."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat. Med."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"e2313","DOI":"10.1002\/rmv.2313","article-title":"Covid-19 vaccines and variants of concern: a review","volume":"32","author":"Hadj","year":"2022","journal-title":"Rev. Med. Virol."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3390\/v14040841","article-title":"Lethal mutagenesis of RNA viruses and approved drugs with antiviral mutagenic activity","volume":"14","author":"Hadj Hassine","year":"2022","journal-title":"Viruses"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nature11228","article-title":"ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation","volume":"487","author":"Hashimoto","year":"2012","journal-title":"Nature"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","article-title":"A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2","volume":"183","author":"Hassan","year":"2020","journal-title":"Cell"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1128\/JVI.02202-13","article-title":"TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein","volume":"88","author":"Heurich","year":"2014","journal-title":"J. Virol."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1001\/jamaneurol.2022.0154","article-title":"Postmortem assessment of olfactory tissue degeneration and microvasculopathy in patients with COVID-19","volume":"79","author":"Ho","year":"2022","journal-title":"JAMA Neurol."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"25018","DOI":"10.1073\/pnas.2010540117","article-title":"Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients","volume":"117","author":"Holter","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1164\/rccm.202005-1885OC","article-title":"Uncontrolled innate and impaired adaptive immune responses in patients with COVID-19 acute respiratory distress syndrome","volume":"202","author":"Hue","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","article-title":"SARS-CoV-2 omicron variant replication in human bronchus and lung ex vivo","volume":"603","author":"Hui","year":"2022","journal-title":"Nature"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"7221","DOI":"10.1128\/JVI.00440-09","article-title":"Identification of in vivo-interacting domains of the murine coronavirus nucleocapsid protein","volume":"83","author":"Hurst","year":"2009","journal-title":"J. Virol."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-022-04594-4","article-title":"Antibody evasion properties of SARS-CoV-2 omicron sublineages","volume":"604","author":"Iketani","year":"2022","journal-title":"Nature"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/oby.22835","article-title":"Does coronavirus disease 2019 disprove the obesity paradox in acute respiratory distress syndrome?","volume":"28","author":"Jose","year":"2020","journal-title":"Obesity (Silver Spring)"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41594-021-00651-0","article-title":"Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis","volume":"28","author":"Kabinger","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"589380","DOI":"10.3389\/fimmu.2020.589380","article-title":"T-cell hyperactivation and paralysis in severe COVID-19 infection revealed by single-cell analysis","volume":"11","author":"Kalfaoglu","year":"2020","journal-title":"Front. Immunol."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/jmv.27515","article-title":"Omicron variant genome evolution and phylogenetics","volume":"94","author":"Kandeel","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"102779","DOI":"10.1016\/j.jaut.2021.102779","article-title":"Omicron SARS-CoV-2 variant: unique features and their impact on pre-existing antibodies","volume":"126","author":"Kannan","year":"2022","journal-title":"J. Autoimmun."},{"key":"ref76","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.1016\/j.cell.2021.10.027","article-title":"Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb","volume":"184","author":"Khan","year":"2021","journal-title":"Cell"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"316","DOI":"10.7150\/thno.49713","article-title":"Immunopathogenesis and treatment of cytokine storm in COVID-19","volume":"11","author":"Kim","year":"2021","journal-title":"Theranostics"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13054-018-2220-9","article-title":"Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers","volume":"22","author":"Knaup","year":"2018","journal-title":"Crit. Care"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"108185","DOI":"10.1016\/j.celrep.2020.108185","article-title":"SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant","volume":"32","author":"Konno","year":"2020","journal-title":"Cell Rep."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1093\/molbev\/msab118","article-title":"An evolutionary portrait of the progenitor SARS-CoV-2 and its dominant offshoots in COVID-19 pandemic","volume":"38","author":"Kumar","year":"2021","journal-title":"Mol. Biol. Evol."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1126\/sciimmunol.abd1554","article-title":"Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19","volume":"5","author":"Lee","year":"2020","journal-title":"Sci Immunol."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s41564-020-00789-5","article-title":"Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies","volume":"5","author":"Lee","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/S2213-2600(20)30404-5","article-title":"Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes","volume":"8","author":"Leisman","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"2000688","DOI":"10.1183\/13993003.00688-2020","article-title":"ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19","volume":"55","author":"Leung","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41467-022-28089-y","article-title":"Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41423-021-00807-4","article-title":"SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy","volume":"19","author":"Li","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1080\/22221751.2021.1969291","article-title":"Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study","volume":"10","author":"Li","year":"2021","journal-title":"Emerg Microbes Infect."},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3389\/fimmu.2020.01022","article-title":"Highlight of immune pathogenic response and Hematopathologic effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 infection","volume":"11","author":"Liang","year":"2020","journal-title":"Front. Immunol."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1093\/nsr\/nwaa247","article-title":"Pathological changes in the lungs and lymphatic organs of 12 COVID-19 autopsy cases","volume":"7","author":"Liu","year":"2020","journal-title":"Natl. Sci. Rev."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1136\/bmj.p1964","article-title":"Covid-19: scientists sound alarm over new BA.2.86 \"Pirola\" variant","volume":"382","author":"Looi","year":"2023","journal-title":"BMJ"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMoa2108891","article-title":"Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant","volume":"385","author":"Lopez Bernal","year":"2021","journal-title":"N Engl J Med Overseas Ed"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1056\/NEJMoa2102214","article-title":"Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant","volume":"384","author":"Madhi","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3389\/fphys.2020.00730","article-title":"Activation of Ang-(1-7)\/mas receptor is a possible strategy to treat coronavirus (SARS-CoV-2) infection","volume":"11","author":"Magalhaes","year":"2020","journal-title":"Front. Physiol."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"n296","DOI":"10.1136\/bmj.n296","article-title":"Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant","volume":"372","author":"Mahase","year":"2021","journal-title":"BMJ"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1136\/bmj.p2097","article-title":"Covid-19: new \"Pirola\" variant BA.2.86 continues to spread in UK and US","volume":"382","author":"Mahase","year":"2023","journal-title":"BMJ"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"155151","DOI":"10.1016\/j.cyto.2020.155151","article-title":"COVID-19 cytokine storm: the anger of inflammation","volume":"133","author":"Mahmudpour","year":"2020","journal-title":"Cytokine"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/d41586-022-00215-2","article-title":"Where did omicron come from? Three key theories","volume":"602","author":"Mallapaty","year":"2022","journal-title":"Nature"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol."},{"key":"ref101","doi-asserted-by":"publisher","first-page":"108598","DOI":"10.1016\/j.clim.2020.108598","article-title":"Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy","volume":"220","author":"Mastellos","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref102","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S1474-4422(20)30308-2","article-title":"Neuropathology of patients with COVID-19 in Germany: a post-mortem case series","volume":"19","author":"Matschke","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref103","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.3390\/v6082991","article-title":"The coronavirus nucleocapsid is a multifunctional protein","volume":"6","author":"McBride","year":"2014","journal-title":"Viruses"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"e437","DOI":"10.1016\/S2665-9913(20)30121-1","article-title":"Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia","volume":"2","author":"McGonagle","year":"","journal-title":"Lancet Rheumatol."},{"key":"ref105","doi-asserted-by":"publisher","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The role of cytokines including Interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease","volume":"19","author":"McGonagle","year":"","journal-title":"Autoimmun. Rev."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","article-title":"Altered TMPRSS2 usage by SARS-CoV-2 omicron impacts infectivity and fusogenicity","volume":"603","author":"Meng","year":"2022","journal-title":"Nature"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"e28848","DOI":"10.1002\/jmv.28848","article-title":"Traceability of SARS-CoV-2 transmission through quasispecies analysis","volume":"95","author":"Messali","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41579-022-00839-1","article-title":"Innate immune evasion strategies of SARS-CoV-2","volume":"21","author":"Minkoff","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref111","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.3389\/fimmu.2020.02037","article-title":"The immune response and immunopathology of COVID-19","volume":"11","author":"Mortaz","year":"2020","journal-title":"Front. Immunol."},{"key":"ref112","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","article-title":"The T cell immune response against SARS-CoV-2","volume":"23","author":"Moss","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref113","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.chom.2021.06.006","article-title":"SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity","volume":"29","author":"Motozono","year":"2021","journal-title":"Cell Host Microbe"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.cell.2022.01.029","article-title":"T cell reactivity to the SARS-CoV-2 omicron variant is preserved in most but not all individuals","volume":"185","author":"Naranbhai","year":"2022","journal-title":"Cell"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"717587","DOI":"10.3389\/fcell.2021.717587","article-title":"Developing cytokine storm-sensitive therapeutic strategy in COVID-19 using 8P9R chimeric peptide and soluble ACE2","volume":"9","author":"Nazerian","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref116","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jsb.2010.11.021","article-title":"A structural analysis of M protein in coronavirus assembly and morphology","volume":"174","author":"Neuman","year":"2011","journal-title":"J. Struct. Biol."},{"key":"ref117","doi-asserted-by":"publisher","first-page":"e1004077","DOI":"10.1371\/journal.ppat.1004077","article-title":"Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis","volume":"10","author":"Nieto-Torres","year":"2014","journal-title":"PLoS Pathog."},{"key":"ref118","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.kint.2020.05.013","article-title":"The case of complement activation in COVID-19 multiorgan impact","volume":"98","author":"Noris","year":"2020","journal-title":"Kidney Int."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"e1128","DOI":"10.1093\/cid\/ciab721","article-title":"Clinical and virological features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern: a retrospective cohort study comparing B.1.1.7 (alpha), B.1.351 (Beta), and B.1.617.2 (Delta)","volume":"75","author":"Ong","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref120","doi-asserted-by":"publisher","first-page":"e1260","DOI":"10.1002\/cti2.1260","article-title":"Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2","volume":"10","author":"Pandey","year":"2021","journal-title":"Clin Transl Immunol."},{"key":"ref121","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.chom.2020.05.008","article-title":"Type I and type III interferons\u2014induction, Signaling, evasion, and application to combat COVID-19","volume":"27","author":"Park","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41581-020-00357-4","article-title":"Immunity, endothelial injury and complement-induced coagulopathy in COVID-19","volume":"17","author":"Perico","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"ref123","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","article-title":"Considerable escape of SARS-CoV-2 omicron to antibody neutralization","volume":"602","author":"Planas","year":"2022","journal-title":"Nature"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1038\/s41591-021-01548-7","article-title":"Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK","volume":"27","author":"Pouwels","year":"2021","journal-title":"Nat. Med."},{"key":"ref125","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jmb.2006.09.074","article-title":"Mosaic structure of human coronavirus NL63, one thousand years of evolution","volume":"364","author":"Pyrc","year":"2006","journal-title":"J. Mol. Biol."},{"key":"ref126","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1038\/s41401-022-00895-6","article-title":"Safety, tolerability, and pharmacokinetics of VV116, an oral nucleoside analog against SARS-CoV-2, in Chinese healthy subjects","volume":"43","author":"Qian","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"ref127","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1002\/jmv.27463","article-title":"COVID-19 vaccines mix-and-match: the concept, the efficacy and the doubts","volume":"94","author":"Rashedi","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref128","doi-asserted-by":"publisher","first-page":"460","DOI":"10.2807\/1560-7917.ES.2023.28.36.2300460","article-title":"First cases of SARS-CoV-2 BA.2.86 in Denmark, 2023","volume":"28","author":"Rasmussen","year":"2023","journal-title":"Euro Surveill."},{"key":"ref129","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/bjh.12629","article-title":"The mechanisms of action of plasma exchange","volume":"164","author":"Reeves","year":"2014","journal-title":"Br. J. Haematol."},{"key":"ref130","doi-asserted-by":"publisher","first-page":"236","DOI":"10.37201\/req\/002.2022","article-title":"Nirmatrelvir plus ritonavir (Paxlovid) a potent SARS-CoV-2 3CLpro protease inhibitor combination","volume":"35","author":"Reina","year":"2022","journal-title":"Rev. Esp. Quimioter."},{"key":"ref131","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jaci.2020.09.009","article-title":"Compartmental immunophenotyping in COVID-19 ARDS: a case series","volume":"147","author":"Ronit","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref132","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1182\/blood-2013-07-516484","article-title":"Synchronized integrin engagement and chemokine activation is crucial in neutrophil extracellular trap-mediated sterile inflammation","volume":"123","author":"Rossaint","year":"2014","journal-title":"Blood"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2009.11.021","article-title":"Gene modulation and immunoregulatory roles of interferon gamma","volume":"50","author":"Saha","year":"2010","journal-title":"Cytokine"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3201\/eid2607.200282","article-title":"High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2","volume":"26","author":"Sanche","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref136","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1097\/JS9.0000000000001070","article-title":"The emergence and implications of SARS-CoV-2 omicron subvariant BA.2.86 on global health","volume":"110","author":"Satapathy","year":"2024","journal-title":"Int. J. Surg."},{"key":"ref137","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"ref138","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.1016\/S2666-5247(20)30144-0","article-title":"Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study","volume":"1","author":"Schurink","year":"2020","journal-title":"Lancet Microbe."},{"key":"ref139","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2807\/1560-7917.ES.2021.26.35.2100793","article-title":"Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to august 2021","volume":"26","author":"Sepp\u00e4l\u00e4","year":"2021","journal-title":"Euro Surveill."},{"key":"ref140","doi-asserted-by":"publisher","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref141","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1080\/22221751.2022.2078230","article-title":"An open, prospective cohort study of VV116 in Chinese participants infected with SARS-CoV-2 omicron variants","volume":"11","author":"Shen","year":"2022","journal-title":"Emerg Microbes Infect."},{"key":"ref142","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","article-title":"COVID-19 infection: origin, transmission, and characteristics of human coronaviruses","volume":"24","author":"Shereen","year":"2020","journal-title":"J. Adv. Res."},{"key":"ref143","doi-asserted-by":"publisher","first-page":"e2381","DOI":"10.1002\/rmv.2381","article-title":"Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: implications for immune escape and transmission","volume":"32","author":"Shrestha","year":"2022","journal-title":"Rev. Med. Virol."},{"key":"ref144","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41467-022-28246-3","article-title":"Tracking cryptic SARS-CoV-2 lineages detected in NYC wastewater","volume":"13","author":"Smyth","year":"2022","journal-title":"Nat. Commun."},{"key":"ref145","author":"Somers","year":"2020"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1161\/HYPERTENSIONAHA.120.15291","article-title":"ACE2 (angiotensin-converting enzyme 2), COVID-19, and ACE inhibitor and Ang II (angiotensin II) receptor blocker use during the pandemic: the Pediatric perspective","volume":"76","author":"South","year":"2020","journal-title":"Hypertension"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"13769","DOI":"10.1128\/JVI.02232-14","article-title":"Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness","volume":"88","author":"Sui","year":"2014","journal-title":"J. Virol."},{"key":"ref148","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41586-022-04462-1","article-title":"Attenuated fusogenicity and pathogenicity of SARS-CoV-2 omicron variant","volume":"603","author":"Suzuki","year":"2022","journal-title":"Nature"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang","year":"","journal-title":"J. Thromb. Haemost."},{"key":"ref150","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1038\/s41591-021-01583-4","article-title":"BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar","volume":"27","author":"Tang","year":"2021","journal-title":"Nat. Med."},{"key":"ref151","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"","journal-title":"J. Thromb. Haemost."},{"key":"ref152","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref153","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","article-title":"COVID-19: the vasculature unleashed","volume":"20","author":"Teuwen","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref154","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1002\/jmv.27541","article-title":"OMICRON (B.1.1.529): a new SARS-CoV-2 variant of concern mounting worldwide fear","volume":"94","author":"Thakur","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref155","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41586-021-03470-x","article-title":"Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England","volume":"593","author":"Volz","year":"2021","journal-title":"Nature"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/jmv.27376","article-title":"The global epidemic of SARS-CoV-2 variants and their mutational immune escape","volume":"94","author":"Tian","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref157","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1473-3099(20)30196-1","article-title":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study","volume":"20","author":"Tsang","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref158","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/jama.2022.2274","article-title":"Estimates of SARS-CoV-2 omicron variant severity in Ontario, Canada","volume":"327","author":"Ulloa","year":"2022","journal-title":"JAMA"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1126\/scitranslmed.abh0755","article-title":"Intranasal ChAdOx1 nCoV-19\/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models","volume":"13","author":"van Doremalen","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref160","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/path.5642","article-title":"COVID-19: immunopathology, pathophysiological mechanisms, and treatment options","volume":"254","author":"van Eijk","year":"2021","journal-title":"J. Pathol."},{"key":"ref161","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/s41591-021-01678-y","article-title":"An infectious SARS-CoV-2 B.1.1.529 omicron virus escapes neutralization by therapeutic monoclonal antibodies","volume":"28","author":"VanBlargan","year":"2022","journal-title":"Nat. Med."},{"key":"ref162","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","article-title":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection","volume":"76","author":"Verdecchia","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"ref164","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"ref166","doi-asserted-by":"publisher","first-page":"e231716","DOI":"10.1148\/radiol.231716","article-title":"COVID-19 Hemiencephalitis: A Unique Manifestation","volume":"310","author":"Wang","year":"2024","journal-title":"Radiology"},{"key":"ref167","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41422-020-00455-9","article-title":"Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages","volume":"31","author":"Wauters","year":"2021","journal-title":"Cell Res."},{"key":"ref168","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.jgg.2021.12.003","article-title":"Evidence for a mouse origin of the SARS-CoV-2 omicron variant","volume":"48","author":"Wei","year":"2021","journal-title":"J. Genet. Genomics"},{"key":"ref169","doi-asserted-by":"publisher","first-page":"312","DOI":"10.7554\/eLife.61312","article-title":"Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants","volume":"9","author":"Weisblum","year":"2020","journal-title":"eLife"},{"key":"ref170","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1080\/07853890.2022.2034936","article-title":"Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19:a meta-analysis","volume":"54","author":"Wen","year":"2022","journal-title":"Ann. Med."},{"key":"ref171","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0140-6736(22)00017-4","article-title":"Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study","volume":"399","author":"Wolter","year":"2022","journal-title":"Lancet"},{"key":"ref172","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41577-021-00656-2","article-title":"Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses\u2014are we our own worst enemy?","volume":"22","author":"Wong","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref173","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"ref174","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41422-022-00706-x","article-title":"Omicron-specific mRNA vaccine elicits potent immune responses in mice, hamsters, and nonhuman primates","volume":"32","author":"Wu","year":"2022","journal-title":"Cell Res."},{"key":"ref175","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.1126\/sciadv.aav4580","article-title":"A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike","volume":"5","author":"Xia","year":"2019","journal-title":"Sci. Adv."},{"key":"ref176","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref177","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3390\/ijms21186582","article-title":"mRNA vaccine era-mechanisms drug platform and clinical prospection","volume":"21","author":"Xu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"ref178","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"ref179","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref180","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1099\/vir.0.81076-0","article-title":"Subcellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein","volume":"86","author":"You","year":"2005","journal-title":"J. Gen. Virol."},{"key":"ref181","doi-asserted-by":"publisher","first-page":"15092","DOI":"10.1038\/ncomms15092","article-title":"Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains","volume":"8","author":"Yuan","year":"2017","journal-title":"Nat. Commun."},{"key":"ref182","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41577-022-00715-2","article-title":"ORF9c and ORF10 as accessory proteins of SARS-CoV-2 in immune evasion","volume":"22","author":"Zandi","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref183","doi-asserted-by":"publisher","first-page":"113889","DOI":"10.1016\/j.biopha.2022.113889","article-title":"The role of SARS-CoV-2 accessory proteins in immune evasion","volume":"156","author":"Zandi","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref184","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.cell.2022.01.024","article-title":"Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia","volume":"185","author":"Zazhytska","year":"2022","journal-title":"Cell"},{"key":"ref185","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cell.2020.03.035","article-title":"A genomic perspective on the origin and emergence of SARS-CoV-2","volume":"181","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"ref186","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41423-022-00837-6","article-title":"Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant","volume":"19","author":"Zhang","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"ref187","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.tibtech.2022.07.012","article-title":"Aptamers targeting SARS-COV-2: a promising tool to fight against COVID-19","volume":"41","author":"Zhang","year":"2023","journal-title":"Trends Biotechnol."},{"key":"ref188","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref189","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41392-021-00852-5","article-title":"SARS-CoV-2 omicron strain exhibits potent capabilities for immune evasion and viral entrance","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref190","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref191","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/s41467-021-21825-w","article-title":"Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2","volume":"12","author":"Zhao","year":"2021","journal-title":"Nat. Commun."},{"key":"ref192","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ijid.2021.11.009","article-title":"Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis","volume":"114","author":"Zheng","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref193","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41423-020-0401-3","article-title":"Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"ref194","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1334152\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T04:57:20Z","timestamp":1718254640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1334152\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":194,"alternative-id":["10.3389\/fmicb.2024.1334152"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2024.1334152","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,13]]},"article-number":"1334152"}}